Fatal acute liver failure during Ritonavir-boosted Paritaprevir, Ombitasvir and Dasabuvir plus Ribavirin therapy

J Gastrointestin Liver Dis. 2017 Mar;26(1):93-94. doi: 10.15403/jgld.2014.1121.261.vir.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • Hepatitis C, Chronic
  • Humans
  • Liver Failure, Acute
  • Ribavirin*
  • Ritonavir*

Substances

  • Antiviral Agents
  • Ribavirin
  • Ritonavir